In summary, adiponectin exerts an indirect influence on osteolytic metastasis in lung cancer primarily through modulating angiogenesis within the tumor microenvironment, participating in the regulation of OC activity, and affecting the equilibrium of bone remodeling. The gene discussed is ADIPOQ; the disease is lung carcinoma.